about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismInhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamsterExploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulationsAssociation of HMG-CoA reductase inhibitors with neuropathy.Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases.Statin-associated peripheral neuropathy: review of the literature.Stroke prevention and statin treatment.Effects of the Cynanchum wilfordii Ethanol Extract on the Serum Lipid Profile in Hypercholesterolemic RatsPhysicians' Experiences as Patients with Statin Side Effects: A Case SeriesNutrition management of amyotrophic lateral sclerosis.Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.Statins and polyneuropathy revisited: case-control study in Denmark, 1999-2013.Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older.Simvastatin-induced mononeuropathy multiplex: case report.Statin-associated adverse cognitive effects: survey results from 171 patients.Are statin medications safe in patients with ALS?Effect of simvastatin on sensorial, motor, and morphological parameters in sciatic nerve crush induced-neuropathic pain in rats.Lipid-lowering drugs (statins) and peripheral neuropathy.The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan.
P2860
Q24603957-A3919F3E-8CE4-4110-8853-6A906F3BDBF3Q24797855-40C9FDAA-BB87-4EDF-8203-9844340E2AECQ28538086-D1B4A803-B272-4F92-A715-ABAAE29A054CQ35054275-CE484787-1F6B-4491-A46F-0491E58BF7AAQ35413815-B396E4EB-2BEB-45BA-B88B-C8DD0CDBAF23Q35906324-0815B424-F423-45BC-9515-32ED4D51AF97Q36533155-6BCD7FE5-91A5-448C-85E0-500989BF6DC4Q37481465-82FC3A8D-E645-4C03-A4A8-660D490F3A35Q37651630-05A196D4-2503-4750-85FB-15BEE71BF0BEQ38087150-01154A07-87A3-4005-9DC7-F9CDB2471EA7Q38274079-5FC93FB0-6003-4FF1-B9A6-8F296C7D903BQ38859474-1F05336E-A063-4E47-A4F5-808DEBC24801Q43779477-8B027936-F0EB-43D7-A4B0-A34EC03B2C96Q44992913-D67264CC-E6C4-44E3-813E-4D3375689B13Q46011754-8E8F17E7-27C1-4148-BB55-561A4B69DF92Q46496531-39CA33B1-3B5C-4B0E-A7BF-EA03D9BD4BD4Q47393675-7EC9822E-3DFC-446F-A932-E6BB5A0BE17FQ55153977-C4A6BA4F-700A-4EDC-8B9C-DB22812D611DQ55237417-C03E4AD7-DB08-4825-AC94-17AFA0233E74
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Peripheral neuropathy associated with simvastatin
@nl
Peripheral neuropathy associated with simvastatin.
@ast
Peripheral neuropathy associated with simvastatin.
@en
type
label
Peripheral neuropathy associated with simvastatin
@nl
Peripheral neuropathy associated with simvastatin.
@ast
Peripheral neuropathy associated with simvastatin.
@en
prefLabel
Peripheral neuropathy associated with simvastatin
@nl
Peripheral neuropathy associated with simvastatin.
@ast
Peripheral neuropathy associated with simvastatin.
@en
P2093
P2860
P356
P1476
Peripheral neuropathy associated with simvastatin.
@en
P2093
P2860
P304
P356
10.1136/JNNP.58.5.625
P407
P577
1995-05-01T00:00:00Z